NF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.349800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.382400E-01
Normal-vs-Stage2
9.083400E-01
Normal-vs-Stage3
1.053990E-01
Normal-vs-Stage4
3.941200E-01
Stage1-vs-Stage2
4.429800E-01
Stage1-vs-Stage3
1.294440E-02
Stage1-vs-Stage4
2.471800E-01
Stage2-vs-Stage3
1.361230E-01
Stage2-vs-Stage4
2.264800E-01
Stage3-vs-Stage4
4.115500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.027000E-01
Normal-vs-AfricanAmerican
5.527400E-01
Normal-vs-Asian
5.249600E-01
Caucasian-vs-AfricanAmerican
2.260400E-01
Caucasian-vs-Asian
3.589800E-01
AfricanAmerican-vs-Asian
1.288370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.868200E-01
Normal-vs-Female
9.980800E-01
Male-vs-Female
5.760000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.210600E-01
Normal-vs-Age(41-60Yrs)
5.569200E-01
Normal-vs-Age(61-80Yrs)
7.064000E-01
Normal-vs-Age(81-100Yrs)
4.028800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.124400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.594630E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.238400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.153200E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.922060E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.452800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.828000E-01
Normal-vs-Daily Drinker
5.343400E-01
Normal-vs-Weekly Drinker
4.868000E-01
Normal-vs-Occasional Drinker
5.594000E-01
Normal-vs-Social Drinker
6.306400E-01
Non Drinker-vs-Daily Drinker
7.063200E-01
Non Drinker-vs-Weekly Drinker
8.668000E-01
Non Drinker-vs-Occasional Drinker
5.356800E-03
Non Drinker-vs-Social Drinker
4.561600E-02
Daily Drinker-vs-Weekly Drinker
8.830400E-01
Daily Drinker-vs-Occasional Drinker
2.647900E-02
Daily Drinker-vs-Social Drinker
5.502500E-02
Weekly Drinker-vs-Occasional Drinker
4.043700E-02
Weekly Drinker-vs-Social Drinker
8.177600E-02
Occasional Drinker-vs-Social Drinker
9.701400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.416000E-02
Normal-vs-Grade 2
3.035700E-03
Normal-vs-Grade 3
1.297590E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.826200E-01
Grade 1-vs-Grade 3
2.524600E-01
Grade 1-vs-Grade 4
7.416000E-02
Grade 2-vs-Grade 3
3.189500E-02
Grade 2-vs-Grade 4
3.035700E-03
Grade 3-vs-Grade 4
1.297590E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.068600E-01
Normal-vs-NonDiabetic
9.156200E-01
Diabetic-vs-NonDiabetic
2.085200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.390600E-01
Normal-vs-NoPancreatitis
8.669000E-01
Pancreatitis-vs-NoPancreatitis
8.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.425000E-01
Normal-vs-N1
9.207400E-01
N0-vs-N1
9.634600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.328200E-01
Normal-vs-TP53-NonMutant
9.709800E-01
TP53-Mutant-vs-TP53-NonMutant
1.039360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
